Small Cell Lung Cancer in Transition: Recent Advances in Biology, Treatment, and Precision Medicine
Recent advances in understanding the disease and improving patient care include adding immune-based treatment to chemotherapy for widespread disease, using durvalumab after combined chemotherapy and radiation for disease limited to the chest, and introducing tarlatamab for cancer that has returned after prior treatment...